CN Patent

CN109789122A — 用于治疗酒精使用病症的组合物、装置和方法

Assigned to Aegis Therapeutics LLC · Expires 2019-05-21 · 7y expired

What this patent protects

提供了适于经鼻递送的药物产品，所述药物产品包括填充有药物组合物的预装填装置，所述药物组合物包含纳曲酮。还提供了制剂和用所述药物产品治疗酒精使用病症和相关病状的方法。

USPTO Abstract

提供了适于经鼻递送的药物产品，所述药物产品包括填充有药物组合物的预装填装置，所述药物组合物包含纳曲酮。还提供了制剂和用所述药物产品治疗酒精使用病症和相关病状的方法。

Drugs covered by this patent

nalmefene-hydrochloride (NALMEFENE HYDROCHLORIDE)

Patent Metadata

Patent number: CN109789122A
Jurisdiction: CN
Classification: —
Expires: 2019-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Aegis Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.